According to a study, patients with ovarian cancer who undergo aggressive surgery have a 70% lower chance of dying.

Published Date: 01 Nov 2023

Three years after a multidisciplinary surgical approach is implemented, patients with ovarian cancer have a seventy percent lower chance of dying. The Mater University Hospital research on advanced ovarian cancer treatment.

Read Full News

Latest News

Freeman’s Lobotomy to Deep Brain Stimulation: What Changed?

The history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.

Prolonged Screen Time Linked to Sleep Issues in Preschoolers

Preschool-aged children exposed to screens for extended daily periods face elevated prevalence of sleep disturbances.

US Mental Health Treatment Rates Rise But Gaps Persist

Treatment rates for US adults with psychiatric disorders are modestly higher than in previous decades, but only a third receive minimally adequate care, new research shows.

Cognitive Bias Modification App Fosters Alcohol Avoidance

An Australian-designed smartphone app uses personalized cognitive bias modification to help users reduce or avoid alcohol consumption.

Schizophrenia: Nighttime Light Tied to Metabolic Dysfunction

Higher vs lower nighttime light exposure is associated with increased risk for obesity, hypertension, and dyslipidemia in patients with schizophrenia, a study suggests.

Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx

Consistently low PSA levels failed to signal metastasis

Todays Updates

Hyponatremia Risk Varies Among Second-Gen Antipsychotics

Aripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.

HCT Survival Outcomes Improving in Relapsed Hodgkin Lymphoma

Researchers evaluate changes in post-transplantation outcomes among patients with relapsed or refractory Hodgkin lymphoma from 2010 to 2022.

How Much of a Cancer Drug Is Too Much?

In a recent KFF survey, 43% of US adults said they had skipped their medication in the past year because of cost.

Todays Updates

Hyponatremia Risk Varies Among Second-Gen Antipsychotics

Aripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.

HCT Survival Outcomes Improving in Relapsed Hodgkin Lymphoma

Researchers evaluate changes in post-transplantation outcomes among patients with relapsed or refractory Hodgkin lymphoma from 2010 to 2022.

How Much of a Cancer Drug Is Too Much?

In a recent KFF survey, 43% of US adults said they had skipped their medication in the past year because of cost.

Latest News

The history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.

Preschool-aged children exposed to screens for extended daily periods face elevated prevalence of sleep disturbances.

Treatment rates for US adults with psychiatric disorders are modestly higher than in previous decades, but only a third receive minimally adequate care, new research shows.

An Australian-designed smartphone app uses personalized cognitive bias modification to help users reduce or avoid alcohol consumption.

Higher vs lower nighttime light exposure is associated with increased risk for obesity, hypertension, and dyslipidemia in patients with schizophrenia, a study suggests.

Consistently low PSA levels failed to signal metastasis

News All Time

Booze and Pancreatic Cancer Risk; From 'Hospice' to 'Hope'; Gen Z-ers Skip Screening

News, features, and commentary about cancer-related issues

Tennessee Pharmacies Sell Potent Ivermectin Pushed by Anti-Vaccine Doctor

"I've taken bucketloads of this stuff," says Denise Sibley

More Americans Are Surviving Cancer. But the Mental Health Challenges Can Persist.

A look at the "silent" impacts of cancer

More Data Back Teclistamab for Autoimmune Disease

Another case series shows most patients improved markedly after failing everything else

Multicomponent Test Tops PSA for Clinically Significant Prostate Cancers

Blood-based biomarker test had similar false-positive rate as PSA, while reducing false negatives

'The Pitt' Actor's Cancer Diagnosis; New HHS Research Plans; Madonna Reveals Injury

Health news and commentary gathered by MedPage Today staff

Nature Retracts Cancer Study Suggesting Treatment Is Better Earlier in the Day

Editors "no longer have confidence in the integrity of the results"

Long-Term CAR-T Results in Lymphoma Confirm Early Promise

Lymphoma-free survival exceeding 5 years in early recipients of the cellular therapy

I Watched My Friend Choose Death. Physician-Assisted Suicide Needs More Guardrails.

And the fundamental question remains of whether doctors should be involved at all

Scream, It's Good for You; Release the Cancer Pigeons; Talk of Chemo Rationing

News, features, and commentary about cancer-related issues

A Cancer Patient's Cats Inspired a Push for Pets in Hospice Wards

The presence of a beloved pet can ease the pain of terminally ill patients, says one doctor

Patellar Resurfacing in Total Knee Replacement; Patient Messaging Trends

Also in TTHealthWatch: tranexamic acid in routine surgery

Study Homes In on Simpler Lung Cancer Screening Criteria

Researchers find benefits, trade-offs using various levels of smoking duration alone

Orca-T Approved to Prevent GVHD After Stem Cell Transplant for Blood Cancers

Regulatory T cell-based immunotherapy approved for use in matched-donor HSCTs

Why Are These Bones and Teeth Where They Shouldn't Be?

Discovery in 31-year-old woman made after she came to the ER with mild abdominal pain

Smoker's Painless Skin Nodules Flag a Fatal Diagnosis

Skin metastasis was the first sign for the otherwise asymptomatic patient

Recommended News For You

New Zealand and Australian breast cancer rates among the highest in the world, global study finds

Aspirin for CRC Risk Reduction May Benefit Unhealthy People Most

Women who miss their first mammogram face higher risk of breast cancer death, study finds

According to a study, there is now a 94 percent survival rate for children with acute lymphatic leukemia.

Getting ahead of head and neck cancer

EBV Screening Tied to Lower Nasopharyngeal Cancer Mortality Risk

Capivasertib Wins Metastatic Prostate Cancer Approval

Recommended Articles For You

What You Need to Know About Correcting Calcium Levels in Patients with Low Albumin  

Genetic Screening: A Game Changer in Cancer Prevention 

Quality of Life Following Organ Function Preserving Oncologic Innovation 

Refining AML Survival: Prognostic Factors, Therapies, and Stem Cell Strategies Reviewed 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Stem Cell Selection Unneeded for SSc Transplant Therapy?

2.

Lung Transplant for Lung Cancer: Promising, in Rare Cases

3.

Rural-urban disparities seen in cervical cancer

4.

Obesity linked to subsequent neoplasms in childhood cancer survivors

5.

New policy review highlights the importance of health-related quality of life in advanced cancer

1.

Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights

2.

Transplant Oncology and Anti-Cancer Immunosuppressants: The Evolution of a Paradigm in Cancer Care

3.

Is AI The New Radiologist For Breast MRI?

4.

Pediatric Oncology at the Cutting Edge: From Early Diagnosis to Lifesaving Therapies

5.

Bone Marrow Regeneration in Hematologic Recovery

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Navigating the Complexities of Ph Negative ALL - Part VI

2.

Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III

4.

Efficient Management of First line ALK-rearranged NSCLC - Part VI

5.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot